Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹116947 Cr.
Stock P/E
58.4
P/B
12.1
Current Price
₹8133.5
Book Value
₹ 673.6
Face Value
5
52W High
₹9326.8
52W Low
₹ 6680
Dividend Yield
0.25%

Apollo Hospital Ent. Overview

Business

Apollo Hospitals Enterprise Ltd. is one of India's largest integrated healthcare providers. Its core business revolves around providing tertiary and quaternary care hospital services across various specialties. The company operates a chain of multi-specialty hospitals, runs a large network of retail pharmacies (Apollo Pharmacy), and also offers primary care clinics, diagnostic centers, and telemedicine services. It makes money primarily through patient fees for medical services, procedures, and surgeries, sales of pharmaceutical products, and charges for diagnostic tests and consultations.

Revenue Mix

While specific revenue contribution figures are not provided, Apollo Hospitals primarily operates through three main segments:

Hospital Services: This is the largest segment, comprising the income generated from medical, surgical, and other healthcare services provided at its multi-specialty hospitals. This includes inpatient and outpatient services, emergency care, organ transplants, and specialized treatments.

Pharmacy Retail: Operated under the "Apollo Pharmacy" brand, this segment involves the sale of medicines, over-the-counter products, and wellness items through a nationwide chain of retail outlets. This is a significant revenue generator and a high-growth area.

Other Healthcare Services: This segment includes revenue from primary care clinics (Apollo Clinics), diagnostic services, health insurance services, medical education, telemedicine, and health IT services.

Industry

The Indian healthcare industry is characterized by significant growth, driven by an aging population, rising disposable incomes, increasing awareness, and a growing burden of chronic diseases. It is a fragmented industry with a mix of public and private players. Apollo Hospitals is a leading player in the private healthcare sector, often considered a pioneer. It holds a dominant position due to its extensive network of hospitals, reputation for complex medical procedures, and comprehensive service offerings, positioning it as a preferred choice for high-quality, advanced medical care in India and for medical tourism.

MOAT

Apollo Hospitals possesses several durable competitive advantages:

Brand Reputation & Trust: Decades of operation have built a strong brand name synonymous with quality, advanced medical care, and patient trust across India, making it a preferred choice for complex treatments.

Scale & Network: As one of the largest private hospital chains with a widespread presence, it benefits from economies of scale in procurement, shared resources, and a broad patient referral network. Its extensive pharmacy chain further strengthens its presence.

Talent Pool: Its reputation and scale attract a large pool of highly skilled doctors, surgeons, and medical professionals, which is crucial in the healthcare industry.

Integrated Model: The comprehensive ecosystem of hospitals, pharmacies, clinics, and diagnostics creates patient stickiness and opportunities for cross-selling.

Growth Drivers

Key factors that can drive growth for Apollo Hospitals over the next 3-5 years include:

Increasing Healthcare Expenditure: Rising per capita income and health consciousness in India are leading to greater spending on private healthcare.

Rising Disease Burden: An increase in lifestyle diseases and chronic conditions necessitates more advanced medical interventions.

Health Insurance Penetration: Growing penetration of health insurance will improve affordability and increase access to private healthcare services.

Medical Tourism: India's cost-effective and high-quality medical treatments attract international patients, with Apollo being a major beneficiary.

Expansion & Digital Health: Continued expansion of its hospital, pharmacy, and clinic network, along with investments in telemedicine and digital health platforms, will broaden its reach.

Risks

Regulatory & Pricing Pressure: Government policies on healthcare pricing, drug price controls, and changes in regulatory frameworks can impact profitability.

Competition: Intense competition from other large hospital chains, regional players, and single-specialty hospitals in key markets.

Talent Acquisition & Retention: Shortage of skilled medical professionals (doctors, nurses) and rising compensation costs can impact operational efficiency and margins.

Capital-Intensive Business: Hospital expansion is highly capital-intensive, requiring significant investment and leading to high debt levels if not managed prudently.

Healthcare Inflation: Rising costs of medical equipment, consumables, and drugs can put pressure on margins.

Litigation Risk: Healthcare providers are exposed to risks of medical malpractice lawsuits.

Management & Ownership

Apollo Hospitals was founded by Dr. Prathap C. Reddy in 1983, and the Reddy family continues to be the promoters and plays a crucial role in its management. The company is professionally managed with a blend of family members and experienced professionals on its board and leadership team. The long-standing involvement of the founding family provides stability and deep industry knowledge, having pioneered private healthcare in India.

Outlook

Apollo Hospitals is well-positioned to capitalize on the robust growth trajectory of the Indian healthcare sector, driven by its established brand, extensive network, and integrated service offerings. Its focus on tertiary care, expanding pharmacy network, and digital health initiatives provide strong avenues for future growth. However, the company faces inherent risks associated with regulatory interventions, intense competition, the capital-intensive nature of hospital expansion, and the ongoing challenge of attracting and retaining top medical talent. Its ability to navigate these challenges while continuing to expand its footprint and maintain service quality will be key to its sustained success.

Apollo Hospital Ent. Share Price

Live · BSE / NSE · Inception: 1979
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

Apollo Hospital Ent. Quarterly Results

#(Fig in Cr.) Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 4944 5086 5589 5527 5592 5842 6304 6477 6606 7044
Other Income 28 37 38 64 61 40 55 53 44 49
Total Income 4972 5123 5628 5591 5653 5882 6358 6530 6649 7092
Total Expenditure 4303 4411 4774 4765 4823 4990 5362 5512 5595 5951
Operating Profit 669 712 854 825 831 892 996 1018 1055 1141
Interest 119 116 118 110 115 108 110 113 119 120
Depreciation 190 177 185 185 211 215 218 219 224 235
Exceptional Income / Expenses 0 0 0 0 0 0 0 -19 0 0
Profit Before Tax 360 419 552 531 505 569 668 667 711 785
Provision for Tax 110 115 162 157 101 142 181 166 170 188
Profit After Tax 250 304 390 374 404 427 488 501 541 597
Adjustments 4 1 -11 -2 -14 5 -11 1 -12 -16
Profit After Adjustments 254 305 379 372 390 433 477 502 529 581
Adjusted Earnings Per Share 17.6 21.2 26.3 25.9 27.1 30.1 33.2 34.9 36.8 40.4

Apollo Hospital Ent. Profit & Loss

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Net Sales 6215 7256 8243 9617 11247 10560 14663 16613 19059 21794 25229 26431
Other Income 53 44 34 32 33 49 78 90 106 200 192 201
Total Income 6267 7300 8277 9650 11280 10609 14741 16703 19166 21994 25420 26629
Total Expenditure 5534 6549 7452 8555 9666 9427 12478 14563 16669 18772 21459 22420
Operating Profit 733 751 825 1095 1614 1182 2263 2140 2497 3222 3961 4210
Interest 180 257 295 327 533 449 379 381 449 459 450 462
Depreciation 264 314 359 396 620 573 601 615 687 758 876 896
Exceptional Income / Expenses 16 0 0 0 198 61 294 0 2 0 -19 -19
Profit Before Tax 332 222 171 373 660 221 1578 1144 1381 2039 2661 2831
Provision for Tax 97 91 112 173 225 85 477 256 446 534 658 705
Profit After Tax 235 131 60 199 435 136 1101 888 935 1505 2003 2127
Adjustments -9 90 58 37 20 14 -46 -68 -36 -59 -61 -38
Profit After Adjustments 226 221 117 236 455 150 1056 819 899 1446 1942 2089
Adjusted Earnings Per Share 16.2 15.9 8.4 17 32.7 10.5 73.4 57 62.5 100.5 135 145.3

Apollo Hospital Ent. Balance Sheet

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Shareholder's Funds 3331 3313 3252 3334 3339 4603 5623 6197 6935 8212 9480
Minority's Interest 78 125 132 136 131 200 280 334 385 441 494
Borrowings 2450 2953 2924 2952 2852 2473 2427 1938 2236 4417 2430
Other Non-Current Liabilities 251 1445 1499 1661 3631 3117 3815 4288 2798 3361 3761
Total Current Liabilities 1250 963 1567 1955 2337 2038 2434 3325 4665 4579 6487
Total Liabilities 7360 8800 9374 10037 12290 12431 14579 16082 17019 21011 22653
Fixed Assets 3997 4583 4766 4975 7426 6773 8291 8516 9661 10985 12269
Other Non-Current Assets 1388 2087 2389 2781 2217 2016 2228 3229 2079 2996 3478
Total Current Assets 1975 2129 2220 2282 2647 3642 4061 4337 5280 7029 6906
Total Assets 7360 8800 9374 10037 12290 12431 14579 16082 17019 21011 22653

Apollo Hospital Ent. Cash Flow

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Opening Cash & Cash Equivalents 340 335 283 306 286 381 389 546 434 506 578
Cash Flow from Operating Activities 597 623 537 905 1293 1265 1696 1377 1920 2136 2856
Cash Flow from Investing Activities -888 -1152 -405 -711 -289 -863 -847 -871 -1537 -3383 -2148
Cash Flow from Financing Activities 330 477 -108 -215 -910 -340 -792 -633 -311 1319 -478
Net Cash Inflow / Outflow 39 -52 24 -20 95 61 57 -127 72 73 230
Closing Cash & Cash Equivalent 379 283 306 286 381 425 547 433 506 578 811

Apollo Hospital Ent. Ratios

# Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Earnings Per Share (Rs) 16.23 15.88 8.44 16.95 32.68 10.46 73.41 56.96 62.49 100.55 135.03
CEPS(Rs) 35.87 32 30.09 42.72 75.76 49.31 118.34 104.51 112.8 157.34 200.19
DPS(Rs) 6 6 5 6 6 3 11.75 15 16 19 20
Book NAV/Share(Rs) 238.81 237.25 233.02 238.71 239.1 319.08 389.89 424.53 469.76 551.27 632
Core EBITDA Margin(%) 10.95 9.74 9.6 11.05 14.06 10.73 14.9 12.34 12.54 13.87 14.94
EBIT Margin(%) 8.24 6.61 5.66 7.27 10.61 6.34 13.34 9.18 9.6 11.46 12.33
Pre Tax Margin(%) 5.34 3.06 2.08 3.87 5.87 2.09 10.76 6.88 7.24 9.36 10.55
PAT Margin (%) 3.79 1.81 0.72 2.07 3.87 1.29 7.51 5.34 4.91 6.91 7.94
Cash Profit Margin (%) 8.03 6.14 5.08 6.18 9.38 6.71 11.61 9.05 8.51 10.38 11.41
ROA(%) 3.4 1.62 0.66 2.05 3.9 1.1 8.15 5.79 5.65 7.92 9.17
ROE(%) 7.25 3.96 1.82 6.07 13.08 3.44 21.6 15.16 14.54 20.5 23.54
ROCE(%) 9.05 7.62 7.12 10.24 17.13 9.32 24.92 17.78 19.27 21.19 21.73
Receivable days 35.79 34.21 34.88 35.08 33.27 40.76 38.53 43.93 45.47 46.32 47.03
Inventory Days 22.21 21.96 22.86 21.83 21.46 17.06 8.48 9.03 8.14 7.88 7.4
Payable days 57.91 53.32 50.11 51.65 53.83 66.42 67.27 75.5 79.74 74.37 62.7
PER(x) 81.6 73.45 125.91 72.02 34.82 277.55 61.52 75.66 101.65 65.86 55.01
Price/Book(x) 5.55 4.92 4.56 5.11 4.76 9.1 11.58 10.15 13.52 12.01 11.75
Dividend Yield(%) 0.45 0.51 0.47 0.49 0.53 0.1 0.26 0.35 0.25 0.29 0.27
EV/Net Sales(x) 3.36 2.6 2.16 2.11 1.69 4.16 4.55 3.85 4.91 4.55 4.41
EV/Core EBITDA(x) 28.49 25.08 21.56 18.56 11.75 37.12 29.45 29.86 37.47 30.77 28.12
Net Sales Growth(%) 20.01 16.75 13.61 16.67 16.94 -6.11 38.85 13.3 14.73 14.35 15.76
EBIT Growth(%) -10.66 -6.39 -2.69 49.96 70.5 -43.84 192.09 -22.09 20.03 36.49 24.54
PAT Growth(%) -27.71 -44.26 -54.58 234.47 118.32 -68.73 709.63 -19.4 5.35 60.97 33.06
EPS Growth(%) -33.56 -2.14 -46.87 100.88 92.75 -68 601.86 -22.4 9.71 60.91 34.29
Debt/Equity(x) 0.85 0.95 1.06 1.1 1.08 0.62 0.47 0.44 0.47 0.67 0.62
Current Ratio(x) 1.58 2.21 1.42 1.17 1.13 1.79 1.67 1.3 1.13 1.54 1.06
Quick Ratio(x) 1.25 1.73 1.06 0.87 0.82 1.66 1.49 1.19 1.03 1.43 0.98
Interest Cover(x) 2.84 1.86 1.58 2.14 2.24 1.49 5.17 4 4.07 5.45 6.92
Total Debt/Mcap(x) 0.15 0.19 0.23 0.22 0.23 0.07 0.04 0.04 0.03 0.06 0.05

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +16% +15% +19% +15%
Operating Profit CAGR +23% +23% +27% +18%
PAT CAGR +33% +31% +71% +24%
Share Price CAGR +9% +17% +13% +20%
ROE Average +24% +20% +19% +12%
ROCE Average +22% +21% +21% +15%

Apollo Hospital Ent. Shareholding Pattern

Latest · Jun 2026
100% held
Promoters 28.02 %
FII 41.5 %
DII (MF + Insurance) 23.95 %
Public (retail) 6.54 %
# Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Promoter 29.3329.3329.3329.3329.3429.3428.0228.0228.0228.02
FII 45.6343.9245.3745.2742.7443.4944.243.5442.6241.5
DII 19.7721.3720.1820.222.5121.5721.3521.7322.9923.95
Public 5.265.385.125.195.415.616.436.716.376.54
Others 0000000000
Total 100100100100100100100100100100

Apollo Hospital Ent. Peer Comparison

Hospital & Healthcare Services Edit Columns

Apollo Hospital Ent. Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Apollo Hospital Ent. Pros & Cons

Pros

  • Company has delivered good profit growth of 71% CAGR over last 5 years
  • Debtor days have improved from 74.37 to 62.7days.
  • Company has reduced debt.

Cons

  • Promoter holding is low: 28.02%.
  • Stock is trading at 12.1 times its book value.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp